Project Grant HT94252410932
Award Date
11/1/24
Completion Date
10/31/26
Dollars Obligated
$154K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Little Rock, AR 72202, USA
Similar Awards
This federal Project Grant award of $693,000.00 from the Defense Health Agency was provided to the Arkansas Children's Research Institute (ACRI) to conduct research on the "Epigenetic Determinants of Corticosteroid Responsiveness in Diamond Blackfan Anemia Syndrome." The award period is from July 1, 2023 to June 30, 2026. ACRI is a pediatric medical research center that conducts clinical trials, provides specialty medical services, and carries out federally-funded research projects...
This Project Grant award for $616,710.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the Children's Research Institute in Washington, D.C. in designing effective adoptive immunotherapy for high-risk pediatric medulloblastoma. The research aims to develop a rational combination with MRI-guided focused ultrasound technology to enhance this innovative cancer treatment approach. The award period runs from August 1, 2024...
The Defense Health Agency awarded a $1,528,727.00 Project Grant to Children's Research Institute, a subsidiary of Children's National Medical Center, to develop SGT-53, a novel nanomedicine that crosses the blood-brain barrier and augments immunotherapeutic response in pediatric brain cancers. This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the...
The Children's Research Institute received a $709,638 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research efforts from May 2021 through April 2024 to enhance T-cell immunotherapy treatments for pediatric patients with relapsed or refractory solid tumors. The Military Medical Research and Development program supports biomedical research that transforms military and public health...
This $524,340 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is funding the development of a rapid drug discovery pipeline for pediatric acute myelogenous leukemia using machine learning and in vitro feedback loops. The Research Institute of the McGill University Health Centre, a non-profit organization, is conducting this research over a 2-year period from Aug 2023 to Aug 2025. The grant supports transforming healthcare...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,295,000.00 to St. Jude Children's Research Hospital Inc. to conduct research aimed at creating cures for patients with Langerhans cell histiocytosis. The award period runs from September 1, 2024 to August 31, 2028. This research project builds upon St. Jude's extensive experience in pediatric cancer and other life-threatening diseases in...
This Project Grant award of $434,993 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Children's Hospital Los Angeles. The funding supports research using high-throughput sequencing of the immunoglobulin loci to develop refined risk stratification methods for pediatric B-cell acute lymphoblastic leukemia (B-ALL). The project aims to advance understanding and treatment of this pediatric cancer, with an expected completion...
The Department of the Army Medical Command awarded a $884,997 Project Grant to the Dana-Farber Cancer Institute, Inc. (doing business as Dfci) under the Military Medical Research and Development program. The three-year grant will fund research to intervene in the TP53 pathway phosphatome in pediatric high-grade gliomas. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research that investigates medical solutions...
The Defense Health Agency awarded a $1,294,957 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to St. Jude Children's Research Hospital in Memphis, Tennessee. The grant, titled "CONQUER: CAR T-CELL LONG-TERM FOLLOW-UP, QUALITY OF LIFE, AND ADVERSE REACTIONS," is for the period of July 1, 2024 to June 30, 2028. The grant supports advanced biomedical research focused on transforming healthcare for military service members and the...
The Department of the Army Medical Command awarded a $777,659 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to the Children's Research Institute (DBA Childrens Research Institute) to conduct research on the "USE OF PRORESOLUTION AND RESTORATIVE PHARMACOLOGY APPROACHES FOR DMD THERAPY". The project seeks to develop novel therapeutic approaches and medical interventions for Duchenne muscular dystrophy, a complex pediatric disease....